The Eph receptors represent the largest family of receptor tyrosine kinases. The Eph receptors and their ephrin ligands are widely expressed during development and in the adult organism, playing important roles in axon guidance, vasculogenesis and cell migration. Eph receptors are unique among other receptor kinases in that they fall into two subclasses with distinct ligand specificities, and in that they can also function as ligands activating bi-directional signaling. Understanding the mechanism of Eph/ephrin signaling requires a detailed structural and biophysical characterization of the Eph receptors, the ephrins, and their interactions with each other and with other regulatory proteins.
The specific aims of our proposed investigations are: 1) Structural characterization of full Eph ectodomains alone and in complex with ephrins; 2) Structural characterization of the interactions of EphB2 with the NMDA Receptor and amyloid precursor protein derived A; 4) Production and structural characterization of functional full-length Eph receptors.

Public Health Relevance

The Eph receptors are the largest receptor tyrosine kinase family. The Ephs and their ephrin ligands are expressed in many tissues during development and in the adult organism and play important roles in diverse processes, including neuronal development, axon guidance, cell migration, tumor progression and metastasis. Our proposal integrates the use of X-ray crystallography with other biophysical, biochemical and cell-biological approaches to study how these molecules recognize and interact with each other, and with other regulatory proteins to activate cell-cell signaling. Currently there are no available crystal structures for any full-length RTK and our long-term goal is to determine the structures of transmembrane Eph receptors and their complexes with ephrins. Ephs are also central players in the crossroads of memory, cognition, and synapse function and malfunction, and that their misregulation leads to neurologic and psychiatric disorders. However, there are no detailed studies establishing the precise molecular mechanism of interaction between Ephs and the NMDA receptor or the amyloid precursor protein derived A. This lack of knowledge has hampered efforts to specifically target these interactions for therapeutic purposes. We, therefore, will carry out detailed biochemical and structural studies on the EphB2/NMDA and EphB2/A interactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS038486-16
Application #
8796234
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Mamounas, Laura
Project Start
1999-02-01
Project End
2019-01-31
Budget Start
2015-02-01
Budget End
2016-01-31
Support Year
16
Fiscal Year
2015
Total Cost
$386,750
Indirect Cost
$168,000
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Seegar, Tom C M; Killingsworth, Lauren B; Saha, Nayanendu et al. (2017) Structural Basis for Regulated Proteolysis by the ?-Secretase ADAM10. Cell 171:1638-1648.e7
Atapattu, Lakmali; Saha, Nayanendu; Chheang, Chanly et al. (2016) An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth. J Exp Med 213:1741-57
Goldgur, Yehuda; Susi, Petri; Karelehto, Eveliina et al. (2014) Generation and characterization of a single-chain anti-EphA2 antibody. Growth Factors 32:214-22
Barton, William A; Dalton, Annamarie C; Seegar, Tom C M et al. (2014) Tie2 and Eph receptor tyrosine kinase activation and signaling. Cold Spring Harb Perspect Biol 6:
Nikolov, Dimitar B; Xu, Kai; Himanen, Juha P (2014) Homotypic receptor-receptor interactions regulating Eph signaling. Cell Adh Migr 8:360-5
Paavilainen, Sari; Grandy, David; Karelehto, Eveliina et al. (2013) High-level expression of a full-length Eph receptor. Protein Expr Purif 92:112-8
Ferluga, Sara; Hantgan, Roy; Goldgur, Yehuda et al. (2013) Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase. J Biol Chem 288:18448-57
Xu, Kai; Tzvetkova-Robev, Dorothea; Xu, Yan et al. (2013) Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5. Proc Natl Acad Sci U S A 110:14634-9
Xu, Kai; Xu, Yan; Rajashankar, Kanagalaghatta R et al. (2013) Crystal structures of Lgr4 and its complex with R-spondin1. Structure 21:1683-9
Nikolov, Dimitar B; Xu, Kai; Himanen, Juha P (2013) Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation. Biochim Biophys Acta 1834:2160-5

Showing the most recent 10 out of 27 publications